NLNL
NewLimit
Reversing biological aging with epigenetics
AISeries AEst. 202110-50 employeesSan Francisco
NewLimit is developing therapies to extend human healthspan by reprogramming the epigenome — the software layer on top of DNA that controls gene expression. Backed by Brian Armstrong (Coinbase CEO), they aim to let humans live longer, healthier lives.
Total Raised$40M
Founders FundForesite Capital
Founders
B
Brian ArmstrongB
Blake ByersMore in AI
Are you the founder?
Add a badge to your site
Show visitors you're featured on Startups.fm.
<a href="https://startups.fm/startups/newlimit" target="_blank" rel="noopener noreferrer"> <img src="https://startups.fm/badge/newlimit" alt="Featured on Startups.fm" height="28" /> </a>
Newsletter
5 startups to watch this week
Funding, jobs & what's being built — every Monday.

